Baudax Bio Inc. (NASDAQ: BXRX) is -39.62% lower on its value in year-to-date trading and has touched a low of $1.25 and a high of $91.20 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BXRX stock was last observed hovering at around $1.33 in the last trading session, with the day’s gains setting it 0.59% off its average median price target of $24.00 for the next 12 months. It is also 92.0% off the consensus price target high of $24.00 offered by 1 analysts, but current levels are 92.0% higher than the price target low of $24.00 for the same period.
Currently trading at $1.92, the stock is -5.79% and -30.05% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 9.58 million and changing 44.36% at the moment leaves the stock -85.81% off its SMA200. BXRX registered -97.04% loss for a year compared to 6-month loss of -85.56%.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
The stock witnessed a -25.29% gain in the last 1 month and extending the period to 3 months gives it a -38.26%, and is 20.00% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.86% over the week and 12.90% over the month.
Baudax Bio Inc. (BXRX) has around 9 employees, a market worth around $5.78M and $1.30M in sales. Distance from 52-week low is 53.60% and -97.89% from its 52-week high. The company has generated returns on investments over the last 12 months (332.20%).
Baudax Bio Inc. (BXRX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Baudax Bio Inc. (BXRX) is a “Hold”. 1 analysts offering their recommendations for the stock have an average rating of 3.00, where 1 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
The EPS is expected to grow by 56.30% this year
Baudax Bio Inc. (BXRX) Top Institutional Holders
The shares outstanding are 0.75M, and float is at 0.50M with Short Float at 7.77%.
Baudax Bio Inc. (BXRX) Insider Activity
A total of 0 insider transactions have happened at Baudax Bio Inc. (BXRX) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider purchase by HENWOOD GERALDINE, the company’s President and CEO. SEC filings show that HENWOOD GERALDINE bought 1,200 shares of the company’s common stock on Dec 15 at a price of $2.55 per share for a total of $3057.0. Following the purchase, the insider now owns 2427.0 shares.